TADFIN Trademark

Trademark Overview

On Wednesday, January 20, 2021, a trademark application was filed for TADFIN with the United States Patent and Trademark Office. The USPTO has given the TADFIN trademark a serial number of 90476857. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 6, 2023. This trademark is owned by Veru Inc.. The TADFIN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical product for treatment of symptoms of an enlarged prostate and for improving urinary flow
tadfin

General Information

Serial Number90476857
Word MarkTADFIN
Filing DateWednesday, January 20, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 6, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 8, 2021

Trademark Statements

Goods and ServicesPharmaceutical product for treatment of symptoms of an enlarged prostate and for improving urinary flow

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 21, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameVeru Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMiami, FL 33127
Party NameVeru Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMiami, FL 33137

Trademark Events

Event DateEvent Description
Monday, March 6, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 6, 2023ABANDONMENT - NO USE STATEMENT FILED
Wednesday, August 3, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 1, 2022SOU EXTENSION 2 GRANTED
Monday, August 1, 2022SOU EXTENSION 2 FILED
Monday, August 1, 2022TEAS EXTENSION RECEIVED
Friday, May 13, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, May 13, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 13, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, May 13, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, May 13, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, January 26, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 24, 2022SOU EXTENSION 1 GRANTED
Monday, January 24, 2022SOU EXTENSION 1 FILED
Monday, January 24, 2022TEAS EXTENSION RECEIVED
Tuesday, August 3, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, July 16, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, July 16, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 16, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, July 16, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, July 16, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, July 7, 2021ASSIGNED TO EXAMINER
Tuesday, June 8, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 8, 2021PUBLISHED FOR OPPOSITION
Wednesday, May 19, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, May 3, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, May 3, 2021EXAMINER'S AMENDMENT ENTERED
Monday, May 3, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, May 3, 2021EXAMINERS AMENDMENT E-MAILED
Monday, May 3, 2021EXAMINERS AMENDMENT -WRITTEN
Tuesday, April 27, 2021ASSIGNED TO EXAMINER
Wednesday, April 21, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, January 23, 2021NEW APPLICATION ENTERED

Related Keywords

tadfin improving urinary flow prostate enlarged product treatment symptoms pharmaceutical